Advertisement

Index by author

June 01, 2010; Volume 77,Issue 6

A

  1. Abada, Paolo B.

    1. Regulation of Copper Transporter 2 Expression by Copper and Cisplatin in Human Ovarian Carcinoma Cells
      Brian G. Blair, Christopher A. Larson, Preston L. Adams, Paolo B. Abada, Roohangiz Safaei and Stephen B. Howell
      Molecular Pharmacology June 2010, 77 (6) 912-921; DOI: https://doi.org/10.1124/mol.109.062836

  2. Adams, Preston L.

    1. Regulation of Copper Transporter 2 Expression by Copper and Cisplatin in Human Ovarian Carcinoma Cells
      Brian G. Blair, Christopher A. Larson, Preston L. Adams, Paolo B. Abada, Roohangiz Safaei and Stephen B. Howell
      Molecular Pharmacology June 2010, 77 (6) 912-921; DOI: https://doi.org/10.1124/mol.109.062836

  3. Airey, David C.

    1. High-Throughput Multiplexed Transcript Analysis Yields Enhanced Resolution of 5-Hydroxytryptamine2C Receptor mRNA Editing Profiles
      Michael V. Morabito, Randi J. Ulbricht, Richard T. O'Neil, David C. Airey, Pengcheng Lu, Bing Zhang, Lily Wang and Ronald B. Emeson
      Molecular Pharmacology June 2010, 77 (6) 895-902; DOI: https://doi.org/10.1124/mol.109.061903

B

  1. Bai, Yuchen

    1. Genetic and Functional Analysis of Human P2X5 Reveals a Distinct Pattern of Exon 10 Polymorphism with Predominant Expression of the Nonfunctional Receptor Isoform
      Smita Kotnis, Brendan Bingham, Dmitry V. Vasilyev, Scott W. Miller, Yuchen Bai, Sarita Yeola, Pranab K. Chanda, Mark R. Bowlby, Edward J. Kaftan, Tarek A. Samad and Garth T. Whiteside
      Molecular Pharmacology June 2010, 77 (6) 953-960; DOI: https://doi.org/10.1124/mol.110.063636

  2. Balghi, Haouaria

    1. Correction of the ΔPhe508 Cystic Fibrosis Transmembrane Conductance Regulator Trafficking Defect by the Bioavailable Compound Glafenine
      Renaud Robert, Graeme W. Carlile, Jie Liao, Haouaria Balghi, Pierre Lesimple, Na Liu, Bart Kus, Daniela Rotin, Martina Wilke, Hugo R. de Jonge, Bob J. Scholte, David Y. Thomas and John W. Hanrahan
      Molecular Pharmacology June 2010, 77 (6) 922-930; DOI: https://doi.org/10.1124/mol.109.062679

  3. Bauer, Jan

    1. Pharmacochaperoning of the A1 Adenosine Receptor Is Contingent on the Endoplasmic Reticulum
      Laura Málaga-Diéguez, Qiong Yang, Jan Bauer, Halyna Pankevych, Michael Freissmuth and Christian Nanoff
      Molecular Pharmacology June 2010, 77 (6) 940-952; DOI: https://doi.org/10.1124/mol.110.063511

  4. Bingham, Brendan

    1. Genetic and Functional Analysis of Human P2X5 Reveals a Distinct Pattern of Exon 10 Polymorphism with Predominant Expression of the Nonfunctional Receptor Isoform
      Smita Kotnis, Brendan Bingham, Dmitry V. Vasilyev, Scott W. Miller, Yuchen Bai, Sarita Yeola, Pranab K. Chanda, Mark R. Bowlby, Edward J. Kaftan, Tarek A. Samad and Garth T. Whiteside
      Molecular Pharmacology June 2010, 77 (6) 953-960; DOI: https://doi.org/10.1124/mol.110.063636

  5. Blair, Brian G.

    1. Regulation of Copper Transporter 2 Expression by Copper and Cisplatin in Human Ovarian Carcinoma Cells
      Brian G. Blair, Christopher A. Larson, Preston L. Adams, Paolo B. Abada, Roohangiz Safaei and Stephen B. Howell
      Molecular Pharmacology June 2010, 77 (6) 912-921; DOI: https://doi.org/10.1124/mol.109.062836

  6. Bowlby, Mark R.

    1. Genetic and Functional Analysis of Human P2X5 Reveals a Distinct Pattern of Exon 10 Polymorphism with Predominant Expression of the Nonfunctional Receptor Isoform
      Smita Kotnis, Brendan Bingham, Dmitry V. Vasilyev, Scott W. Miller, Yuchen Bai, Sarita Yeola, Pranab K. Chanda, Mark R. Bowlby, Edward J. Kaftan, Tarek A. Samad and Garth T. Whiteside
      Molecular Pharmacology June 2010, 77 (6) 953-960; DOI: https://doi.org/10.1124/mol.110.063636

C

  1. Carlile, Graeme W.

    1. Correction of the ΔPhe508 Cystic Fibrosis Transmembrane Conductance Regulator Trafficking Defect by the Bioavailable Compound Glafenine
      Renaud Robert, Graeme W. Carlile, Jie Liao, Haouaria Balghi, Pierre Lesimple, Na Liu, Bart Kus, Daniela Rotin, Martina Wilke, Hugo R. de Jonge, Bob J. Scholte, David Y. Thomas and John W. Hanrahan
      Molecular Pharmacology June 2010, 77 (6) 922-930; DOI: https://doi.org/10.1124/mol.109.062679

  2. Chanda, Pranab K.

    1. Genetic and Functional Analysis of Human P2X5 Reveals a Distinct Pattern of Exon 10 Polymorphism with Predominant Expression of the Nonfunctional Receptor Isoform
      Smita Kotnis, Brendan Bingham, Dmitry V. Vasilyev, Scott W. Miller, Yuchen Bai, Sarita Yeola, Pranab K. Chanda, Mark R. Bowlby, Edward J. Kaftan, Tarek A. Samad and Garth T. Whiteside
      Molecular Pharmacology June 2010, 77 (6) 953-960; DOI: https://doi.org/10.1124/mol.110.063636

  3. Chapman-Smith, Anne

    1. Amino Acid Substitutions in the Aryl Hydrocarbon Receptor Ligand Binding Domain Reveal YH439 As an Atypical AhR Activator
      Fiona Whelan, Nan Hao, Sebastian G. B. Furness, Murray L. Whitelaw and Anne Chapman-Smith
      Molecular Pharmacology June 2010, 77 (6) 1037-1046; DOI: https://doi.org/10.1124/mol.109.062927

  4. Chen, Xiao-Bo

    1. EP1 Prostanoid Receptor Coupling to Gi/o Up-Regulates the Expression of Hypoxia-Inducible Factor-1α through Activation of a Phosphoinositide-3 Kinase Signaling Pathway
      Ruyue Ji, Chih-Ling Chou, Wei Xu, Xiao-Bo Chen, David F. Woodward and John W. Regan
      Molecular Pharmacology June 2010, 77 (6) 1025-1036; DOI: https://doi.org/10.1124/mol.110.063933

  5. Chou, Chih-Ling

    1. EP1 Prostanoid Receptor Coupling to Gi/o Up-Regulates the Expression of Hypoxia-Inducible Factor-1α through Activation of a Phosphoinositide-3 Kinase Signaling Pathway
      Ruyue Ji, Chih-Ling Chou, Wei Xu, Xiao-Bo Chen, David F. Woodward and John W. Regan
      Molecular Pharmacology June 2010, 77 (6) 1025-1036; DOI: https://doi.org/10.1124/mol.110.063933

D

  1. de Jonge, Hugo R.

    1. Correction of the ΔPhe508 Cystic Fibrosis Transmembrane Conductance Regulator Trafficking Defect by the Bioavailable Compound Glafenine
      Renaud Robert, Graeme W. Carlile, Jie Liao, Haouaria Balghi, Pierre Lesimple, Na Liu, Bart Kus, Daniela Rotin, Martina Wilke, Hugo R. de Jonge, Bob J. Scholte, David Y. Thomas and John W. Hanrahan
      Molecular Pharmacology June 2010, 77 (6) 922-930; DOI: https://doi.org/10.1124/mol.109.062679

  2. Ding, Zhao

    1. Binding of Inositol 1,4,5-trisphosphate (IP3) and Adenophostin A to the N-Terminal region of the IP3 Receptor: Thermodynamic Analysis Using Fluorescence Polarization with a Novel IP3 Receptor Ligand
      Zhao Ding, Ana M. Rossi, Andrew M. Riley, Taufiq Rahman, Barry V. L. Potter and Colin W. Taylor
      Molecular Pharmacology June 2010, 77 (6) 995-1004; DOI: https://doi.org/10.1124/mol.109.062596

  3. Dong, Liang

    1. Asymmetric Acetylation of the Cyclooxygenase-2 Homodimer by Aspirin and Its Effects on the Oxygenation of Arachidonic, Eicosapentaenoic, and Docosahexaenoic Acids
      Narayan P. Sharma, Liang Dong, Chong Yuan, Kathleen R. Noon and William L. Smith
      Molecular Pharmacology June 2010, 77 (6) 979-986; DOI: https://doi.org/10.1124/mol.109.063115

E

  1. Emeson, Ronald B.

    1. High-Throughput Multiplexed Transcript Analysis Yields Enhanced Resolution of 5-Hydroxytryptamine2C Receptor mRNA Editing Profiles
      Michael V. Morabito, Randi J. Ulbricht, Richard T. O'Neil, David C. Airey, Pengcheng Lu, Bing Zhang, Lily Wang and Ronald B. Emeson
      Molecular Pharmacology June 2010, 77 (6) 895-902; DOI: https://doi.org/10.1124/mol.109.061903

F

  1. Ferguson, Stephen S. G.

    1. The Angiotensin II Type 1 Receptor Induces Membrane Blebbing by Coupling to Rho A, Rho Kinase, and Myosin Light Chain Kinase
      Christina M. Godin and Stephen S. G. Ferguson
      Molecular Pharmacology June 2010, 77 (6) 903-911; DOI: https://doi.org/10.1124/mol.110.063859

  2. Finel, Moshe

    1. A Molecular Model of the Human UDP-Glucuronosyltransferase 1A1, Its Membrane Orientation, and the Interactions between Different Parts of the Enzyme
      Liisa Laakkonen and Moshe Finel
      Molecular Pharmacology June 2010, 77 (6) 931-939; DOI: https://doi.org/10.1124/mol.109.063289

  3. Freissmuth, Michael

    1. Pharmacochaperoning of the A1 Adenosine Receptor Is Contingent on the Endoplasmic Reticulum
      Laura Málaga-Diéguez, Qiong Yang, Jan Bauer, Halyna Pankevych, Michael Freissmuth and Christian Nanoff
      Molecular Pharmacology June 2010, 77 (6) 940-952; DOI: https://doi.org/10.1124/mol.110.063511

  4. Furness, Sebastian G. B.

    1. Amino Acid Substitutions in the Aryl Hydrocarbon Receptor Ligand Binding Domain Reveal YH439 As an Atypical AhR Activator
      Fiona Whelan, Nan Hao, Sebastian G. B. Furness, Murray L. Whitelaw and Anne Chapman-Smith
      Molecular Pharmacology June 2010, 77 (6) 1037-1046; DOI: https://doi.org/10.1124/mol.109.062927

G

  1. Godin, Christina M.

    1. The Angiotensin II Type 1 Receptor Induces Membrane Blebbing by Coupling to Rho A, Rho Kinase, and Myosin Light Chain Kinase
      Christina M. Godin and Stephen S. G. Ferguson
      Molecular Pharmacology June 2010, 77 (6) 903-911; DOI: https://doi.org/10.1124/mol.110.063859

H

  1. Hanrahan, John W.

    1. Correction of the ΔPhe508 Cystic Fibrosis Transmembrane Conductance Regulator Trafficking Defect by the Bioavailable Compound Glafenine
      Renaud Robert, Graeme W. Carlile, Jie Liao, Haouaria Balghi, Pierre Lesimple, Na Liu, Bart Kus, Daniela Rotin, Martina Wilke, Hugo R. de Jonge, Bob J. Scholte, David Y. Thomas and John W. Hanrahan
      Molecular Pharmacology June 2010, 77 (6) 922-930; DOI: https://doi.org/10.1124/mol.109.062679

  2. Hao, Nan

    1. Amino Acid Substitutions in the Aryl Hydrocarbon Receptor Ligand Binding Domain Reveal YH439 As an Atypical AhR Activator
      Fiona Whelan, Nan Hao, Sebastian G. B. Furness, Murray L. Whitelaw and Anne Chapman-Smith
      Molecular Pharmacology June 2010, 77 (6) 1037-1046; DOI: https://doi.org/10.1124/mol.109.062927

  3. Hepler, John R.

    1. PAR1 and PAR2 Couple to Overlapping and Distinct Sets of G Proteins and Linked Signaling Pathways to Differentially Regulate Cell Physiology
      Kelly L. McCoy, Stephen F. Traynelis and John R. Hepler
      Molecular Pharmacology June 2010, 77 (6) 1005-1015; DOI: https://doi.org/10.1124/mol.109.062018

  4. Howell, Stephen B.

    1. Copper Transporters and the Cellular Pharmacology of the Platinum-Containing Cancer Drugs
      Stephen B. Howell, Roohangiz Safaei, Christopher A. Larson and Michael J. Sailor
      Molecular Pharmacology June 2010, 77 (6) 887-894; DOI: https://doi.org/10.1124/mol.109.063172
    2. Regulation of Copper Transporter 2 Expression by Copper and Cisplatin in Human Ovarian Carcinoma Cells
      Brian G. Blair, Christopher A. Larson, Preston L. Adams, Paolo B. Abada, Roohangiz Safaei and Stephen B. Howell
      Molecular Pharmacology June 2010, 77 (6) 912-921; DOI: https://doi.org/10.1124/mol.109.062836

I

  1. Ichimura, Atsuhiko

    1. MicroRNA-34a Inhibits Cell Proliferation by Repressing Mitogen-Activated Protein Kinase Kinase 1 during Megakaryocytic Differentiation of K562 Cells
      Atsuhiko Ichimura, Yoshinao Ruike, Kazuya Terasawa, Kazuharu Shimizu and Gozoh Tsujimoto
      Molecular Pharmacology June 2010, 77 (6) 1016-1024; DOI: https://doi.org/10.1124/mol.109.063321

J

  1. Ji, Ruyue

    1. EP1 Prostanoid Receptor Coupling to Gi/o Up-Regulates the Expression of Hypoxia-Inducible Factor-1α through Activation of a Phosphoinositide-3 Kinase Signaling Pathway
      Ruyue Ji, Chih-Ling Chou, Wei Xu, Xiao-Bo Chen, David F. Woodward and John W. Regan
      Molecular Pharmacology June 2010, 77 (6) 1025-1036; DOI: https://doi.org/10.1124/mol.110.063933

  2. Jiang, Wei

    1. Identification of Hydroxyxanthones as Na/K-ATPase Ligands
      Zhongbing Zhang, Zhichuan Li, Jiang Tian, Wei Jiang, Yin Wang, Xiaojin Zhang, Zhuorong Li, Qidong You, Joseph I. Shapiro, Shuyi Si and Zijian Xie
      Molecular Pharmacology June 2010, 77 (6) 961-967; DOI: https://doi.org/10.1124/mol.110.063974

K

  1. Kaftan, Edward J.

    1. Genetic and Functional Analysis of Human P2X5 Reveals a Distinct Pattern of Exon 10 Polymorphism with Predominant Expression of the Nonfunctional Receptor Isoform
      Smita Kotnis, Brendan Bingham, Dmitry V. Vasilyev, Scott W. Miller, Yuchen Bai, Sarita Yeola, Pranab K. Chanda, Mark R. Bowlby, Edward J. Kaftan, Tarek A. Samad and Garth T. Whiteside
      Molecular Pharmacology June 2010, 77 (6) 953-960; DOI: https://doi.org/10.1124/mol.110.063636

  2. Kotnis, Smita

    1. Genetic and Functional Analysis of Human P2X5 Reveals a Distinct Pattern of Exon 10 Polymorphism with Predominant Expression of the Nonfunctional Receptor Isoform
      Smita Kotnis, Brendan Bingham, Dmitry V. Vasilyev, Scott W. Miller, Yuchen Bai, Sarita Yeola, Pranab K. Chanda, Mark R. Bowlby, Edward J. Kaftan, Tarek A. Samad and Garth T. Whiteside
      Molecular Pharmacology June 2010, 77 (6) 953-960; DOI: https://doi.org/10.1124/mol.110.063636

  3. Kus, Bart

    1. Correction of the ΔPhe508 Cystic Fibrosis Transmembrane Conductance Regulator Trafficking Defect by the Bioavailable Compound Glafenine
      Renaud Robert, Graeme W. Carlile, Jie Liao, Haouaria Balghi, Pierre Lesimple, Na Liu, Bart Kus, Daniela Rotin, Martina Wilke, Hugo R. de Jonge, Bob J. Scholte, David Y. Thomas and John W. Hanrahan
      Molecular Pharmacology June 2010, 77 (6) 922-930; DOI: https://doi.org/10.1124/mol.109.062679

L

  1. Laakkonen, Liisa

    1. A Molecular Model of the Human UDP-Glucuronosyltransferase 1A1, Its Membrane Orientation, and the Interactions between Different Parts of the Enzyme
      Liisa Laakkonen and Moshe Finel
      Molecular Pharmacology June 2010, 77 (6) 931-939; DOI: https://doi.org/10.1124/mol.109.063289

  2. Larson, Christopher A.

    1. Copper Transporters and the Cellular Pharmacology of the Platinum-Containing Cancer Drugs
      Stephen B. Howell, Roohangiz Safaei, Christopher A. Larson and Michael J. Sailor
      Molecular Pharmacology June 2010, 77 (6) 887-894; DOI: https://doi.org/10.1124/mol.109.063172
    2. Regulation of Copper Transporter 2 Expression by Copper and Cisplatin in Human Ovarian Carcinoma Cells
      Brian G. Blair, Christopher A. Larson, Preston L. Adams, Paolo B. Abada, Roohangiz Safaei and Stephen B. Howell
      Molecular Pharmacology June 2010, 77 (6) 912-921; DOI: https://doi.org/10.1124/mol.109.062836

  3. Ledent, Catherine

    1. Priming of Signal Transducer and Activator of Transcription Proteins for Cytokine-Triggered Polyubiquitylation and Degradation by the A2A Adenosine Receptor
      Mohammed M. A. Safhi, Claire Rutherford, Catherine Ledent, William A. Sands and Timothy M. Palmer
      Molecular Pharmacology June 2010, 77 (6) 968-978; DOI: https://doi.org/10.1124/mol.109.062455

  4. Lee, Andy C.

    1. Up-Regulation of Human CYP2J2 in HepG2 Cells by Butylated Hydroxyanisole Is Mediated by c-Jun and Nrf2
      Andy C. Lee and Michael Murray
      Molecular Pharmacology June 2010, 77 (6) 987-994; DOI: https://doi.org/10.1124/mol.109.062729

  5. Lesimple, Pierre

    1. Correction of the ΔPhe508 Cystic Fibrosis Transmembrane Conductance Regulator Trafficking Defect by the Bioavailable Compound Glafenine
      Renaud Robert, Graeme W. Carlile, Jie Liao, Haouaria Balghi, Pierre Lesimple, Na Liu, Bart Kus, Daniela Rotin, Martina Wilke, Hugo R. de Jonge, Bob J. Scholte, David Y. Thomas and John W. Hanrahan
      Molecular Pharmacology June 2010, 77 (6) 922-930; DOI: https://doi.org/10.1124/mol.109.062679

  6. Li, Zhichuan

    1. Identification of Hydroxyxanthones as Na/K-ATPase Ligands
      Zhongbing Zhang, Zhichuan Li, Jiang Tian, Wei Jiang, Yin Wang, Xiaojin Zhang, Zhuorong Li, Qidong You, Joseph I. Shapiro, Shuyi Si and Zijian Xie
      Molecular Pharmacology June 2010, 77 (6) 961-967; DOI: https://doi.org/10.1124/mol.110.063974

  7. Li, Zhuorong

    1. Identification of Hydroxyxanthones as Na/K-ATPase Ligands
      Zhongbing Zhang, Zhichuan Li, Jiang Tian, Wei Jiang, Yin Wang, Xiaojin Zhang, Zhuorong Li, Qidong You, Joseph I. Shapiro, Shuyi Si and Zijian Xie
      Molecular Pharmacology June 2010, 77 (6) 961-967; DOI: https://doi.org/10.1124/mol.110.063974

  8. Liao, Jie

    1. Correction of the ΔPhe508 Cystic Fibrosis Transmembrane Conductance Regulator Trafficking Defect by the Bioavailable Compound Glafenine
      Renaud Robert, Graeme W. Carlile, Jie Liao, Haouaria Balghi, Pierre Lesimple, Na Liu, Bart Kus, Daniela Rotin, Martina Wilke, Hugo R. de Jonge, Bob J. Scholte, David Y. Thomas and John W. Hanrahan
      Molecular Pharmacology June 2010, 77 (6) 922-930; DOI: https://doi.org/10.1124/mol.109.062679

  9. Liu, Na

    1. Correction of the ΔPhe508 Cystic Fibrosis Transmembrane Conductance Regulator Trafficking Defect by the Bioavailable Compound Glafenine
      Renaud Robert, Graeme W. Carlile, Jie Liao, Haouaria Balghi, Pierre Lesimple, Na Liu, Bart Kus, Daniela Rotin, Martina Wilke, Hugo R. de Jonge, Bob J. Scholte, David Y. Thomas and John W. Hanrahan
      Molecular Pharmacology June 2010, 77 (6) 922-930; DOI: https://doi.org/10.1124/mol.109.062679

  10. Lu, Pengcheng

    1. High-Throughput Multiplexed Transcript Analysis Yields Enhanced Resolution of 5-Hydroxytryptamine2C Receptor mRNA Editing Profiles
      Michael V. Morabito, Randi J. Ulbricht, Richard T. O'Neil, David C. Airey, Pengcheng Lu, Bing Zhang, Lily Wang and Ronald B. Emeson
      Molecular Pharmacology June 2010, 77 (6) 895-902; DOI: https://doi.org/10.1124/mol.109.061903

M

  1. Málaga-Diéguez, Laura

    1. Pharmacochaperoning of the A1 Adenosine Receptor Is Contingent on the Endoplasmic Reticulum
      Laura Málaga-Diéguez, Qiong Yang, Jan Bauer, Halyna Pankevych, Michael Freissmuth and Christian Nanoff
      Molecular Pharmacology June 2010, 77 (6) 940-952; DOI: https://doi.org/10.1124/mol.110.063511

  2. McCoy, Kelly L.

    1. PAR1 and PAR2 Couple to Overlapping and Distinct Sets of G Proteins and Linked Signaling Pathways to Differentially Regulate Cell Physiology
      Kelly L. McCoy, Stephen F. Traynelis and John R. Hepler
      Molecular Pharmacology June 2010, 77 (6) 1005-1015; DOI: https://doi.org/10.1124/mol.109.062018

  3. Miller, Scott W.

    1. Genetic and Functional Analysis of Human P2X5 Reveals a Distinct Pattern of Exon 10 Polymorphism with Predominant Expression of the Nonfunctional Receptor Isoform
      Smita Kotnis, Brendan Bingham, Dmitry V. Vasilyev, Scott W. Miller, Yuchen Bai, Sarita Yeola, Pranab K. Chanda, Mark R. Bowlby, Edward J. Kaftan, Tarek A. Samad and Garth T. Whiteside
      Molecular Pharmacology June 2010, 77 (6) 953-960; DOI: https://doi.org/10.1124/mol.110.063636

  4. Morabito, Michael V.

    1. High-Throughput Multiplexed Transcript Analysis Yields Enhanced Resolution of 5-Hydroxytryptamine2C Receptor mRNA Editing Profiles
      Michael V. Morabito, Randi J. Ulbricht, Richard T. O'Neil, David C. Airey, Pengcheng Lu, Bing Zhang, Lily Wang and Ronald B. Emeson
      Molecular Pharmacology June 2010, 77 (6) 895-902; DOI: https://doi.org/10.1124/mol.109.061903

  5. Murray, Michael

    1. Up-Regulation of Human CYP2J2 in HepG2 Cells by Butylated Hydroxyanisole Is Mediated by c-Jun and Nrf2
      Andy C. Lee and Michael Murray
      Molecular Pharmacology June 2010, 77 (6) 987-994; DOI: https://doi.org/10.1124/mol.109.062729

N

  1. Nanoff, Christian

    1. Pharmacochaperoning of the A1 Adenosine Receptor Is Contingent on the Endoplasmic Reticulum
      Laura Málaga-Diéguez, Qiong Yang, Jan Bauer, Halyna Pankevych, Michael Freissmuth and Christian Nanoff
      Molecular Pharmacology June 2010, 77 (6) 940-952; DOI: https://doi.org/10.1124/mol.110.063511

  2. Noon, Kathleen R.

    1. Asymmetric Acetylation of the Cyclooxygenase-2 Homodimer by Aspirin and Its Effects on the Oxygenation of Arachidonic, Eicosapentaenoic, and Docosahexaenoic Acids
      Narayan P. Sharma, Liang Dong, Chong Yuan, Kathleen R. Noon and William L. Smith
      Molecular Pharmacology June 2010, 77 (6) 979-986; DOI: https://doi.org/10.1124/mol.109.063115

O

  1. O'Neil, Richard T.

    1. High-Throughput Multiplexed Transcript Analysis Yields Enhanced Resolution of 5-Hydroxytryptamine2C Receptor mRNA Editing Profiles
      Michael V. Morabito, Randi J. Ulbricht, Richard T. O'Neil, David C. Airey, Pengcheng Lu, Bing Zhang, Lily Wang and Ronald B. Emeson
      Molecular Pharmacology June 2010, 77 (6) 895-902; DOI: https://doi.org/10.1124/mol.109.061903

P

  1. Palmer, Timothy M.

    1. Priming of Signal Transducer and Activator of Transcription Proteins for Cytokine-Triggered Polyubiquitylation and Degradation by the A2A Adenosine Receptor
      Mohammed M. A. Safhi, Claire Rutherford, Catherine Ledent, William A. Sands and Timothy M. Palmer
      Molecular Pharmacology June 2010, 77 (6) 968-978; DOI: https://doi.org/10.1124/mol.109.062455

  2. Pankevych, Halyna

    1. Pharmacochaperoning of the A1 Adenosine Receptor Is Contingent on the Endoplasmic Reticulum
      Laura Málaga-Diéguez, Qiong Yang, Jan Bauer, Halyna Pankevych, Michael Freissmuth and Christian Nanoff
      Molecular Pharmacology June 2010, 77 (6) 940-952; DOI: https://doi.org/10.1124/mol.110.063511

  3. Potter, Barry V. L.

    1. Binding of Inositol 1,4,5-trisphosphate (IP3) and Adenophostin A to the N-Terminal region of the IP3 Receptor: Thermodynamic Analysis Using Fluorescence Polarization with a Novel IP3 Receptor Ligand
      Zhao Ding, Ana M. Rossi, Andrew M. Riley, Taufiq Rahman, Barry V. L. Potter and Colin W. Taylor
      Molecular Pharmacology June 2010, 77 (6) 995-1004; DOI: https://doi.org/10.1124/mol.109.062596

R

  1. Rahman, Taufiq

    1. Binding of Inositol 1,4,5-trisphosphate (IP3) and Adenophostin A to the N-Terminal region of the IP3 Receptor: Thermodynamic Analysis Using Fluorescence Polarization with a Novel IP3 Receptor Ligand
      Zhao Ding, Ana M. Rossi, Andrew M. Riley, Taufiq Rahman, Barry V. L. Potter and Colin W. Taylor
      Molecular Pharmacology June 2010, 77 (6) 995-1004; DOI: https://doi.org/10.1124/mol.109.062596

  2. Regan, John W.

    1. EP1 Prostanoid Receptor Coupling to Gi/o Up-Regulates the Expression of Hypoxia-Inducible Factor-1α through Activation of a Phosphoinositide-3 Kinase Signaling Pathway
      Ruyue Ji, Chih-Ling Chou, Wei Xu, Xiao-Bo Chen, David F. Woodward and John W. Regan
      Molecular Pharmacology June 2010, 77 (6) 1025-1036; DOI: https://doi.org/10.1124/mol.110.063933

  3. Riley, Andrew M.

    1. Binding of Inositol 1,4,5-trisphosphate (IP3) and Adenophostin A to the N-Terminal region of the IP3 Receptor: Thermodynamic Analysis Using Fluorescence Polarization with a Novel IP3 Receptor Ligand
      Zhao Ding, Ana M. Rossi, Andrew M. Riley, Taufiq Rahman, Barry V. L. Potter and Colin W. Taylor
      Molecular Pharmacology June 2010, 77 (6) 995-1004; DOI: https://doi.org/10.1124/mol.109.062596

  4. Robert, Renaud

    1. Correction of the ΔPhe508 Cystic Fibrosis Transmembrane Conductance Regulator Trafficking Defect by the Bioavailable Compound Glafenine
      Renaud Robert, Graeme W. Carlile, Jie Liao, Haouaria Balghi, Pierre Lesimple, Na Liu, Bart Kus, Daniela Rotin, Martina Wilke, Hugo R. de Jonge, Bob J. Scholte, David Y. Thomas and John W. Hanrahan
      Molecular Pharmacology June 2010, 77 (6) 922-930; DOI: https://doi.org/10.1124/mol.109.062679

  5. Rossi, Ana M.

    1. Binding of Inositol 1,4,5-trisphosphate (IP3) and Adenophostin A to the N-Terminal region of the IP3 Receptor: Thermodynamic Analysis Using Fluorescence Polarization with a Novel IP3 Receptor Ligand
      Zhao Ding, Ana M. Rossi, Andrew M. Riley, Taufiq Rahman, Barry V. L. Potter and Colin W. Taylor
      Molecular Pharmacology June 2010, 77 (6) 995-1004; DOI: https://doi.org/10.1124/mol.109.062596

  6. Rotin, Daniela

    1. Correction of the ΔPhe508 Cystic Fibrosis Transmembrane Conductance Regulator Trafficking Defect by the Bioavailable Compound Glafenine
      Renaud Robert, Graeme W. Carlile, Jie Liao, Haouaria Balghi, Pierre Lesimple, Na Liu, Bart Kus, Daniela Rotin, Martina Wilke, Hugo R. de Jonge, Bob J. Scholte, David Y. Thomas and John W. Hanrahan
      Molecular Pharmacology June 2010, 77 (6) 922-930; DOI: https://doi.org/10.1124/mol.109.062679

  7. Ruike, Yoshinao

    1. MicroRNA-34a Inhibits Cell Proliferation by Repressing Mitogen-Activated Protein Kinase Kinase 1 during Megakaryocytic Differentiation of K562 Cells
      Atsuhiko Ichimura, Yoshinao Ruike, Kazuya Terasawa, Kazuharu Shimizu and Gozoh Tsujimoto
      Molecular Pharmacology June 2010, 77 (6) 1016-1024; DOI: https://doi.org/10.1124/mol.109.063321

  8. Rutherford, Claire

    1. Priming of Signal Transducer and Activator of Transcription Proteins for Cytokine-Triggered Polyubiquitylation and Degradation by the A2A Adenosine Receptor
      Mohammed M. A. Safhi, Claire Rutherford, Catherine Ledent, William A. Sands and Timothy M. Palmer
      Molecular Pharmacology June 2010, 77 (6) 968-978; DOI: https://doi.org/10.1124/mol.109.062455

S

  1. Safaei, Roohangiz

    1. Copper Transporters and the Cellular Pharmacology of the Platinum-Containing Cancer Drugs
      Stephen B. Howell, Roohangiz Safaei, Christopher A. Larson and Michael J. Sailor
      Molecular Pharmacology June 2010, 77 (6) 887-894; DOI: https://doi.org/10.1124/mol.109.063172
    2. Regulation of Copper Transporter 2 Expression by Copper and Cisplatin in Human Ovarian Carcinoma Cells
      Brian G. Blair, Christopher A. Larson, Preston L. Adams, Paolo B. Abada, Roohangiz Safaei and Stephen B. Howell
      Molecular Pharmacology June 2010, 77 (6) 912-921; DOI: https://doi.org/10.1124/mol.109.062836

  2. Safhi, Mohammed M. A.

    1. Priming of Signal Transducer and Activator of Transcription Proteins for Cytokine-Triggered Polyubiquitylation and Degradation by the A2A Adenosine Receptor
      Mohammed M. A. Safhi, Claire Rutherford, Catherine Ledent, William A. Sands and Timothy M. Palmer
      Molecular Pharmacology June 2010, 77 (6) 968-978; DOI: https://doi.org/10.1124/mol.109.062455

  3. Sailor, Michael J.

    1. Copper Transporters and the Cellular Pharmacology of the Platinum-Containing Cancer Drugs
      Stephen B. Howell, Roohangiz Safaei, Christopher A. Larson and Michael J. Sailor
      Molecular Pharmacology June 2010, 77 (6) 887-894; DOI: https://doi.org/10.1124/mol.109.063172

  4. Samad, Tarek A.

    1. Genetic and Functional Analysis of Human P2X5 Reveals a Distinct Pattern of Exon 10 Polymorphism with Predominant Expression of the Nonfunctional Receptor Isoform
      Smita Kotnis, Brendan Bingham, Dmitry V. Vasilyev, Scott W. Miller, Yuchen Bai, Sarita Yeola, Pranab K. Chanda, Mark R. Bowlby, Edward J. Kaftan, Tarek A. Samad and Garth T. Whiteside
      Molecular Pharmacology June 2010, 77 (6) 953-960; DOI: https://doi.org/10.1124/mol.110.063636

  5. Sands, William A.

    1. Priming of Signal Transducer and Activator of Transcription Proteins for Cytokine-Triggered Polyubiquitylation and Degradation by the A2A Adenosine Receptor
      Mohammed M. A. Safhi, Claire Rutherford, Catherine Ledent, William A. Sands and Timothy M. Palmer
      Molecular Pharmacology June 2010, 77 (6) 968-978; DOI: https://doi.org/10.1124/mol.109.062455

  6. Scholte, Bob J.

    1. Correction of the ΔPhe508 Cystic Fibrosis Transmembrane Conductance Regulator Trafficking Defect by the Bioavailable Compound Glafenine
      Renaud Robert, Graeme W. Carlile, Jie Liao, Haouaria Balghi, Pierre Lesimple, Na Liu, Bart Kus, Daniela Rotin, Martina Wilke, Hugo R. de Jonge, Bob J. Scholte, David Y. Thomas and John W. Hanrahan
      Molecular Pharmacology June 2010, 77 (6) 922-930; DOI: https://doi.org/10.1124/mol.109.062679

  7. Shapiro, Joseph I.

    1. Identification of Hydroxyxanthones as Na/K-ATPase Ligands
      Zhongbing Zhang, Zhichuan Li, Jiang Tian, Wei Jiang, Yin Wang, Xiaojin Zhang, Zhuorong Li, Qidong You, Joseph I. Shapiro, Shuyi Si and Zijian Xie
      Molecular Pharmacology June 2010, 77 (6) 961-967; DOI: https://doi.org/10.1124/mol.110.063974

  8. Sharma, Narayan P.

    1. Asymmetric Acetylation of the Cyclooxygenase-2 Homodimer by Aspirin and Its Effects on the Oxygenation of Arachidonic, Eicosapentaenoic, and Docosahexaenoic Acids
      Narayan P. Sharma, Liang Dong, Chong Yuan, Kathleen R. Noon and William L. Smith
      Molecular Pharmacology June 2010, 77 (6) 979-986; DOI: https://doi.org/10.1124/mol.109.063115

  9. Shimizu, Kazuharu

    1. MicroRNA-34a Inhibits Cell Proliferation by Repressing Mitogen-Activated Protein Kinase Kinase 1 during Megakaryocytic Differentiation of K562 Cells
      Atsuhiko Ichimura, Yoshinao Ruike, Kazuya Terasawa, Kazuharu Shimizu and Gozoh Tsujimoto
      Molecular Pharmacology June 2010, 77 (6) 1016-1024; DOI: https://doi.org/10.1124/mol.109.063321

  10. Si, Shuyi

    1. Identification of Hydroxyxanthones as Na/K-ATPase Ligands
      Zhongbing Zhang, Zhichuan Li, Jiang Tian, Wei Jiang, Yin Wang, Xiaojin Zhang, Zhuorong Li, Qidong You, Joseph I. Shapiro, Shuyi Si and Zijian Xie
      Molecular Pharmacology June 2010, 77 (6) 961-967; DOI: https://doi.org/10.1124/mol.110.063974

  11. Smith, William L.

    1. Asymmetric Acetylation of the Cyclooxygenase-2 Homodimer by Aspirin and Its Effects on the Oxygenation of Arachidonic, Eicosapentaenoic, and Docosahexaenoic Acids
      Narayan P. Sharma, Liang Dong, Chong Yuan, Kathleen R. Noon and William L. Smith
      Molecular Pharmacology June 2010, 77 (6) 979-986; DOI: https://doi.org/10.1124/mol.109.063115

T

  1. Taylor, Colin W.

    1. Binding of Inositol 1,4,5-trisphosphate (IP3) and Adenophostin A to the N-Terminal region of the IP3 Receptor: Thermodynamic Analysis Using Fluorescence Polarization with a Novel IP3 Receptor Ligand
      Zhao Ding, Ana M. Rossi, Andrew M. Riley, Taufiq Rahman, Barry V. L. Potter and Colin W. Taylor
      Molecular Pharmacology June 2010, 77 (6) 995-1004; DOI: https://doi.org/10.1124/mol.109.062596

  2. Terasawa, Kazuya

    1. MicroRNA-34a Inhibits Cell Proliferation by Repressing Mitogen-Activated Protein Kinase Kinase 1 during Megakaryocytic Differentiation of K562 Cells
      Atsuhiko Ichimura, Yoshinao Ruike, Kazuya Terasawa, Kazuharu Shimizu and Gozoh Tsujimoto
      Molecular Pharmacology June 2010, 77 (6) 1016-1024; DOI: https://doi.org/10.1124/mol.109.063321

  3. Thomas, David Y.

    1. Correction of the ΔPhe508 Cystic Fibrosis Transmembrane Conductance Regulator Trafficking Defect by the Bioavailable Compound Glafenine
      Renaud Robert, Graeme W. Carlile, Jie Liao, Haouaria Balghi, Pierre Lesimple, Na Liu, Bart Kus, Daniela Rotin, Martina Wilke, Hugo R. de Jonge, Bob J. Scholte, David Y. Thomas and John W. Hanrahan
      Molecular Pharmacology June 2010, 77 (6) 922-930; DOI: https://doi.org/10.1124/mol.109.062679

  4. Tian, Jiang

    1. Identification of Hydroxyxanthones as Na/K-ATPase Ligands
      Zhongbing Zhang, Zhichuan Li, Jiang Tian, Wei Jiang, Yin Wang, Xiaojin Zhang, Zhuorong Li, Qidong You, Joseph I. Shapiro, Shuyi Si and Zijian Xie
      Molecular Pharmacology June 2010, 77 (6) 961-967; DOI: https://doi.org/10.1124/mol.110.063974

  5. Traynelis, Stephen F.

    1. PAR1 and PAR2 Couple to Overlapping and Distinct Sets of G Proteins and Linked Signaling Pathways to Differentially Regulate Cell Physiology
      Kelly L. McCoy, Stephen F. Traynelis and John R. Hepler
      Molecular Pharmacology June 2010, 77 (6) 1005-1015; DOI: https://doi.org/10.1124/mol.109.062018

  6. Tsujimoto, Gozoh

    1. MicroRNA-34a Inhibits Cell Proliferation by Repressing Mitogen-Activated Protein Kinase Kinase 1 during Megakaryocytic Differentiation of K562 Cells
      Atsuhiko Ichimura, Yoshinao Ruike, Kazuya Terasawa, Kazuharu Shimizu and Gozoh Tsujimoto
      Molecular Pharmacology June 2010, 77 (6) 1016-1024; DOI: https://doi.org/10.1124/mol.109.063321

U

  1. Ulbricht, Randi J.

    1. High-Throughput Multiplexed Transcript Analysis Yields Enhanced Resolution of 5-Hydroxytryptamine2C Receptor mRNA Editing Profiles
      Michael V. Morabito, Randi J. Ulbricht, Richard T. O'Neil, David C. Airey, Pengcheng Lu, Bing Zhang, Lily Wang and Ronald B. Emeson
      Molecular Pharmacology June 2010, 77 (6) 895-902; DOI: https://doi.org/10.1124/mol.109.061903

V

  1. Vasilyev, Dmitry V.

    1. Genetic and Functional Analysis of Human P2X5 Reveals a Distinct Pattern of Exon 10 Polymorphism with Predominant Expression of the Nonfunctional Receptor Isoform
      Smita Kotnis, Brendan Bingham, Dmitry V. Vasilyev, Scott W. Miller, Yuchen Bai, Sarita Yeola, Pranab K. Chanda, Mark R. Bowlby, Edward J. Kaftan, Tarek A. Samad and Garth T. Whiteside
      Molecular Pharmacology June 2010, 77 (6) 953-960; DOI: https://doi.org/10.1124/mol.110.063636

W

  1. Wang, Lily

    1. High-Throughput Multiplexed Transcript Analysis Yields Enhanced Resolution of 5-Hydroxytryptamine2C Receptor mRNA Editing Profiles
      Michael V. Morabito, Randi J. Ulbricht, Richard T. O'Neil, David C. Airey, Pengcheng Lu, Bing Zhang, Lily Wang and Ronald B. Emeson
      Molecular Pharmacology June 2010, 77 (6) 895-902; DOI: https://doi.org/10.1124/mol.109.061903

  2. Wang, Yin

    1. Identification of Hydroxyxanthones as Na/K-ATPase Ligands
      Zhongbing Zhang, Zhichuan Li, Jiang Tian, Wei Jiang, Yin Wang, Xiaojin Zhang, Zhuorong Li, Qidong You, Joseph I. Shapiro, Shuyi Si and Zijian Xie
      Molecular Pharmacology June 2010, 77 (6) 961-967; DOI: https://doi.org/10.1124/mol.110.063974

  3. Whelan, Fiona

    1. Amino Acid Substitutions in the Aryl Hydrocarbon Receptor Ligand Binding Domain Reveal YH439 As an Atypical AhR Activator
      Fiona Whelan, Nan Hao, Sebastian G. B. Furness, Murray L. Whitelaw and Anne Chapman-Smith
      Molecular Pharmacology June 2010, 77 (6) 1037-1046; DOI: https://doi.org/10.1124/mol.109.062927

  4. Whitelaw, Murray L.

    1. Amino Acid Substitutions in the Aryl Hydrocarbon Receptor Ligand Binding Domain Reveal YH439 As an Atypical AhR Activator
      Fiona Whelan, Nan Hao, Sebastian G. B. Furness, Murray L. Whitelaw and Anne Chapman-Smith
      Molecular Pharmacology June 2010, 77 (6) 1037-1046; DOI: https://doi.org/10.1124/mol.109.062927

  5. Whiteside, Garth T.

    1. Genetic and Functional Analysis of Human P2X5 Reveals a Distinct Pattern of Exon 10 Polymorphism with Predominant Expression of the Nonfunctional Receptor Isoform
      Smita Kotnis, Brendan Bingham, Dmitry V. Vasilyev, Scott W. Miller, Yuchen Bai, Sarita Yeola, Pranab K. Chanda, Mark R. Bowlby, Edward J. Kaftan, Tarek A. Samad and Garth T. Whiteside
      Molecular Pharmacology June 2010, 77 (6) 953-960; DOI: https://doi.org/10.1124/mol.110.063636

  6. Wilke, Martina

    1. Correction of the ΔPhe508 Cystic Fibrosis Transmembrane Conductance Regulator Trafficking Defect by the Bioavailable Compound Glafenine
      Renaud Robert, Graeme W. Carlile, Jie Liao, Haouaria Balghi, Pierre Lesimple, Na Liu, Bart Kus, Daniela Rotin, Martina Wilke, Hugo R. de Jonge, Bob J. Scholte, David Y. Thomas and John W. Hanrahan
      Molecular Pharmacology June 2010, 77 (6) 922-930; DOI: https://doi.org/10.1124/mol.109.062679

  7. Woodward, David F.

    1. EP1 Prostanoid Receptor Coupling to Gi/o Up-Regulates the Expression of Hypoxia-Inducible Factor-1α through Activation of a Phosphoinositide-3 Kinase Signaling Pathway
      Ruyue Ji, Chih-Ling Chou, Wei Xu, Xiao-Bo Chen, David F. Woodward and John W. Regan
      Molecular Pharmacology June 2010, 77 (6) 1025-1036; DOI: https://doi.org/10.1124/mol.110.063933

X

  1. Xie, Zijian

    1. Identification of Hydroxyxanthones as Na/K-ATPase Ligands
      Zhongbing Zhang, Zhichuan Li, Jiang Tian, Wei Jiang, Yin Wang, Xiaojin Zhang, Zhuorong Li, Qidong You, Joseph I. Shapiro, Shuyi Si and Zijian Xie
      Molecular Pharmacology June 2010, 77 (6) 961-967; DOI: https://doi.org/10.1124/mol.110.063974

  2. Xu, Wei

    1. EP1 Prostanoid Receptor Coupling to Gi/o Up-Regulates the Expression of Hypoxia-Inducible Factor-1α through Activation of a Phosphoinositide-3 Kinase Signaling Pathway
      Ruyue Ji, Chih-Ling Chou, Wei Xu, Xiao-Bo Chen, David F. Woodward and John W. Regan
      Molecular Pharmacology June 2010, 77 (6) 1025-1036; DOI: https://doi.org/10.1124/mol.110.063933

Y

  1. Yang, Qiong

    1. Pharmacochaperoning of the A1 Adenosine Receptor Is Contingent on the Endoplasmic Reticulum
      Laura Málaga-Diéguez, Qiong Yang, Jan Bauer, Halyna Pankevych, Michael Freissmuth and Christian Nanoff
      Molecular Pharmacology June 2010, 77 (6) 940-952; DOI: https://doi.org/10.1124/mol.110.063511

  2. Yeola, Sarita

    1. Genetic and Functional Analysis of Human P2X5 Reveals a Distinct Pattern of Exon 10 Polymorphism with Predominant Expression of the Nonfunctional Receptor Isoform
      Smita Kotnis, Brendan Bingham, Dmitry V. Vasilyev, Scott W. Miller, Yuchen Bai, Sarita Yeola, Pranab K. Chanda, Mark R. Bowlby, Edward J. Kaftan, Tarek A. Samad and Garth T. Whiteside
      Molecular Pharmacology June 2010, 77 (6) 953-960; DOI: https://doi.org/10.1124/mol.110.063636

  3. You, Qidong

    1. Identification of Hydroxyxanthones as Na/K-ATPase Ligands
      Zhongbing Zhang, Zhichuan Li, Jiang Tian, Wei Jiang, Yin Wang, Xiaojin Zhang, Zhuorong Li, Qidong You, Joseph I. Shapiro, Shuyi Si and Zijian Xie
      Molecular Pharmacology June 2010, 77 (6) 961-967; DOI: https://doi.org/10.1124/mol.110.063974

  4. Yuan, Chong

    1. Asymmetric Acetylation of the Cyclooxygenase-2 Homodimer by Aspirin and Its Effects on the Oxygenation of Arachidonic, Eicosapentaenoic, and Docosahexaenoic Acids
      Narayan P. Sharma, Liang Dong, Chong Yuan, Kathleen R. Noon and William L. Smith
      Molecular Pharmacology June 2010, 77 (6) 979-986; DOI: https://doi.org/10.1124/mol.109.063115

Z

  1. Zhang, Bing

    1. High-Throughput Multiplexed Transcript Analysis Yields Enhanced Resolution of 5-Hydroxytryptamine2C Receptor mRNA Editing Profiles
      Michael V. Morabito, Randi J. Ulbricht, Richard T. O'Neil, David C. Airey, Pengcheng Lu, Bing Zhang, Lily Wang and Ronald B. Emeson
      Molecular Pharmacology June 2010, 77 (6) 895-902; DOI: https://doi.org/10.1124/mol.109.061903

  2. Zhang, Xiaojin

    1. Identification of Hydroxyxanthones as Na/K-ATPase Ligands
      Zhongbing Zhang, Zhichuan Li, Jiang Tian, Wei Jiang, Yin Wang, Xiaojin Zhang, Zhuorong Li, Qidong You, Joseph I. Shapiro, Shuyi Si and Zijian Xie
      Molecular Pharmacology June 2010, 77 (6) 961-967; DOI: https://doi.org/10.1124/mol.110.063974

  3. Zhang, Zhongbing

    1. Identification of Hydroxyxanthones as Na/K-ATPase Ligands
      Zhongbing Zhang, Zhichuan Li, Jiang Tian, Wei Jiang, Yin Wang, Xiaojin Zhang, Zhuorong Li, Qidong You, Joseph I. Shapiro, Shuyi Si and Zijian Xie
      Molecular Pharmacology June 2010, 77 (6) 961-967; DOI: https://doi.org/10.1124/mol.110.063974
Back to top

In this issue